Sung Lee
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sung Lee
Sung Lee is recorded as Board Member at Tango Therapeutics, Inc. (TNGX). Tango Therapeutics, Inc. reported in an 8-K filed May 13, 2026 that Sung Lee was appointed Lead Independent Director, effective May 13, 2026.
“In connection with Mr. Borisy's and Mr. Pothula's resignations from the Board, the Board appointed Sung Lee as Lead Independent Director of the Board and the Chairperson of the Compensation Committee and as a member thereof, each effective as of May 13, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tango Therapeutics, Inc. (TNGX)
SEC 8-K
Current2026-05-13–present
-
Current
2026-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Malte Peters, M.D. CEO
- Barbara Weber Chairman
- Barbara Weber, M.D. Chairman
- Matthew Gall CFO
- Douglas Barry General Counsel
- Jessica Newcomb Chief Accounting Officer
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.